Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,800
Closed -$750K 850
2025
Q2
$750K Buy
5,800
+3,700
+176% +$448K 0.02% 507
2025
Q1
$251K Buy
+2,100
New +$260K 0.01% 736
2024
Q4
Sell
-1,600
Closed -$216K 1042
2024
Q3
$216K Sell
1,600
-600
-27% -$80.3K ﹤0.01% 838
2024
Q2
$298K Buy
+2,200
New +$299K 0.01% 793
2024
Q1
Sell
-1,900
Closed -$217K 1036
2023
Q4
$217K Sell
1,900
-1,200
-39% -$120K ﹤0.01% 880
2023
Q3
$282K Buy
+3,100
New +$320K ﹤0.01% 957
2021
Q4
Sell
-20,900
Closed -$2.58M 1196
2021
Q3
$2.58M Buy
20,900
+9,700
+87% +$1.25M 0.08% 186
2021
Q2
$1.34M Buy
+11,200
New +$1.28M 0.05% 337

Other funds holding XYL

Maven Securities's XYL Position: Q1 2024 in Review

Maven Securities sold out of Xylem (XYL) in Q1 2024, closing a stake of 1,918 shares — an estimated $219K sold.

Maven Securities first reported a position in XYL in Q2 2021 and held it in 4 quarters. The position peaked at $266K in Q3 2021. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Maven Securities reported no remaining Xylem position as of Q1 2024 after selling out during the quarter.
  • Maven Securities sold 1,918 Xylem shares in Q1 2024, an estimated $219K.
  • Maven Securities first reported a position in Xylem in Q2 2021 and held it in 4 quarters.
  • Maven Securities's Xylem position peaked at $266K in Q3 2021.
  • 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Maven Securities's 13F filing for Q1 2024, filed 14 May 2024.